| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.1 | 0.05 |